LLY Eli Lilly and Company

LLY Eli Lilly and Company

Healthcare · Drug Manufacturers - General

Desk view

Watchingmedium conviction · entry $1160-$1197 — not entered
Basis Logged decision ·Entry target
Updated

Market read

Scan convergence 4 scans as of 2026-10-16 2 bull 2 neutral converging

POC $1,028 · VWAP $1,050 · +19.7% vs 12m avg buyer

basing vol: normalgaps: overnight-shiftchurn: quiet as of

Insiders quiet 0 buy / 0 sell · Form 4, 90d

Cluster EVP, SVP + 1 other sold $16M, Aug 10–18

Coverage

LLY Price Structure

Loading chart…

Loading timeframes…

Peers

Every watchlist LLY belongs to, members best 30-day change first — LLY highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.

@peptide-economy
@biotech
@healthcare-scan
@healthcare
@biotech-scan
@insider-universe
View watchlist →
MRNA+49.7% -7.8%1d -3.1%7d SHOP+30.4% -4.8%1d -0.8%7d PINS+17.5% -3.5%1d +2.4%7d ISRGE+11.6% -0.3%1d +0.7%7d LLY+10.5% +0.4%1d +6.6%7d ZS+8.3% -5.9%1d -11.3%7d MSFT+7.9% -1.9%1d -1.1%7d ESTC+7.9% -5.7%1d -6.6%7d DDOG+7.1% -7.2%1d -15.7%7d PLTR+6.7% -7.2%1d -11.0%7d TMO+6.4% -0.9%1d +4.9%7d META+5.3% -3.7%1d -1.3%7d UI+5.3% -2.8%1d -8.6%7d COIN+5.3% -5.8%1d -3.5%7d CEG+4.6% -1.3%1d -9.0%7d RBLX+4.5% -3.1%1d +3.0%7d ABNB+3.7% -0.3%1d +4.7%7d AFRM+3.4% -2.5%1d -8.3%7d AAPL+3.3% +0.4%1d +2.0%7d AMD+3.2% -6.0%1d -13.1%7d ASML+2.5% -1.0%1d -7.8%7d ZM+2.5% -4.4%1d -3.6%7d TWLO+2.3% -10.6%1d -15.6%7d ASAN+2.2% -5.4%1d -2.1%7d AMZN+1.6% -1.9%1d -4.7%7d NOW+1.5% -4.4%1d +0.8%7d HIMS+0.3% -4.5%1d -9.2%7d NVDA+0.1% -1.4%1d -6.6%7d NTLA-0.6% +0.7%1d -12.6%7d GOOGL-0.7% -2.5%1d -3.1%7d MRVL-0.8% -5.6%1d -17.2%7d UBER-0.9% -1.3%1d -1.6%7d TSLA-0.9% -2.1%1d -7.3%7d TSM-1.2% -2.3%1d -9.0%7d FTNT-1.5% -7.0%1d -13.2%7d VRTX-2.6% -1.8%1d -2.0%7d AVGO-3.2% -4.5%1d -9.1%7d CRM-3.9% -2.5%1d +5.0%7d U-4.1% -6.8%1d -13.8%7d FSLY-4.5% -10.4%1d -23.3%7d IBKR-4.7% -3.9%1d -5.9%7d CRSP-5.7% -4.4%1d -7.8%7d CRWD-5.8% -7.0%1d -17.3%7d ARM-6.6% -6.9%1d -14.4%7d QCOM-6.9% -3.5%1d -1.9%7d SNOW-7.3% -8.4%1d -16.8%7d NFLXE-7.7% -2.9%1d +0.3%7d BNTX-8.5% -2.8%1d -9.5%7d NET-8.7% -6.3%1d -17.9%7d PANW-9.0% -7.6%1d -18.3%7d FSLR-9.7% -3.5%1d -2.9%7d MDB-10.3% -7.9%1d -12.5%7d INTC-11.1% -5.8%1d -14.2%7d SOFI-13.6% -3.6%1d -7.9%7d ENPH-13.9% -0.7%1d -6.7%7d AKAM-16.0% -4.9%1d -17.9%7d BE-18.0% -6.3%1d -21.1%7d DOCN-20.3% -9.8%1d -26.8%7d EOSE-53.8% -15.7%1d -27.8%7d

Decision history

4 scored calls · newest first · projection

How to read this: Positive 30-day excess supports an enter call. For pass, avoid, sell, or exit calls, a positive number means the name kept rising after the call.

Jun 27 sell n/a Profit target -2.4% complete
May 30 sell n/a Profit target +15.7% complete
May 30 sell n/a Profit target +15.7% complete
May 2 sell n/a Momentum recovery exit +6.3% complete

Desk commentary

Authored analysis and challenge notes tied to LLY.

2

Next earnings LLY reports in 12 days Oct 29

Last report Aug 5

News coverage shows Eli Lilly's second-quarter 2026 print had already landed by the time of tonight's pull. Reuters (July 31) reported Lilly beat estimates on resilient demand for its GLP-1 drugs Mounjaro and Zepbound, widening its lead over Novo Nordisk.

full note →

Against street estimates

How LLY's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.

8 most recent of 11 quarters · newest report Aug 5 · projection Oct 16

Result
Aug 5 6.588.38+27.3%Beat
Apr 30 6.798.55+25.9%Beat
Feb 4 6.917.54+9.1%Beat
Oct 30 '25 5.897.02+19.1%Beat
Aug 7 '25 5.596.31+12.9%Beat
May 1 '25 3.463.34-3.4%Miss
Feb 6 '25 5.075.32+5.0%Beat
Oct 30 '24 1.471.18-19.5%Miss

Recent news

Headlines about LLY from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.

pulled today · Oct 17

“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.

Types
Aug 5 Catalyst LLY earnings
LLY
Apr 27 Reference YOLO Playbook
Mar 31 Article Daily Actions
Mar 24 Article Daily Actions